AKT1 and rheumatoid arthritis: The results identified 59 KRCG of HGWD in treating RA and further revealed their potential pharmacological mechanisms for inhibiting the inflammatory response by synergistically targeting the cAMP, PI3K-Akt, and HIF-1α pathways.